Praj Industries Ltd Q4 FY25 Earnings Analysis
Published 7 Aug 2026 | Industrial Manufacturing | Market Cap: ₹5.8K Cr
Price
₹326
Market Cap
₹5.8K Cr
P/E Ratio
293.6
Earnings Summary
- Targeting 3x revenue growth by 2030, aiming for Rs. - Praj Industries targets 3x revenue growth and 5x bottom-line growth by FY30 (Page 13).
📊 Revenue & Sales Performance
- Targeting 3x revenue growth by 2030, aiming for Rs. 10,000 crores topline. - International revenue expected to grow 8x from Rs. 665 crores in FY24 to approx. Rs. 5,000 crores by FY30. - Goal to achieve a 50:50 revenue split between domestic and international markets by FY30. - Growth driven by GenX products, bioenergy (bio-ethanol and biofuels), and Clean Process Engineering Solutions (CPES). - Bioenergy business, including international biofuel projects in Brazil and Tanzania, expected to expand significantly. - Adoption and development of SAF (Sustainable Aviation Fuel) and ATJ (Alcohol to Jet) routes to augment revenue streams. - CBG (Compressed Bio-Gas) segment at a nascent stage but poised for increased traction with multiple projects under construction. - Domestic market growth supported by blending mandates (e.g., 20% ethanol blending target). - Bio-bitumen and fertilizer by-products present future growth opportunities.
📈 Profitability & Margins
- Praj Industries targets 3x revenue growth and 5x bottom-line growth by FY30 (Page 13). - The company aims for a 50%-50% revenue split between domestic and international markets by FY30, with international growth expected to outpace domestic (Page 6). - Margin performance depends on product mix; expected positive margin trends over time despite short-term dips (Page 11). - Bioenergy business, including SAF and bio-ethanol, is a key driver for growth and improved margins, especially from international markets (Pages 19-20). - Expenses related to GenX facility expected to moderate as revenues from this facility increase in coming years (Pages 8-9). - Execution delays affect short-term revenue but expected to normalize from FY26, leading to stronger earnings (Page 11). - Overall, Praj remains confident of delivering on guidance with strong order backlog and expanding international footprint (Pages 3, 6).
🏗️ Capital Expenditure Plans
- Formation of JV between Praj and BPCL approved by respective boards to set up CBG plants across India. Capital commitment and structure to be finalized based on number of projects; detailed work ongoing (Page 10). - Mangalore engineering facility fully ready with over Rs. 200 crores invested in CAPEX and about Rs. 80 crores in operating expenses YTD. Delays in land acquisition impacted current year activity; revenues expected from H2 FY26 (Page 4). - Future capital investments linked to JV projects, SAF plants, international expansion, and technology innovations in zero liquid discharge and bioplastics (Pages 4, 22). - Strategic investments focus on entering new markets (internationalization target 50% revenue by 2030), technology leadership in bioenergy, SAF, and CBG ecosystems (Pages 4, 6, 22). - Capital investment amounts for JV and other projects will be clearer after project finalization expected within the next 3-4 months (Page 10).
💰 Fundraising & Capital Structure
- There is no explicit mention of any current or planned new fundraising through debt or equity in the provided transcript sections. - The company discussed investments in facilities (e.g., GenX plant at Mangalore) and operating expenses but did not reference raising capital through equity or debt issuance. - Cash in hand as of December 31 is Rs. 6.4 billion, indicating available liquidity. - The discussion indicates focus on revenue growth and margin improvement rather than new fundraising. - No direct comments were made regarding plans for debt or equity fundraising in near future during the Q&A or management commentary.
📋 Order Book & Pipeline
- Order backlog as of December 24th stands at Rs. 43.5 billion. - 75% of the order backlog is from the domestic market. - Order intake during Q3 FY25 was Rs. 10.5 billion. - 60% of the quarterly order intake came from the domestic market. - 77% of the order intake is from bioenergy, 17% from engineering, and 6% from PHS business. - Share of international order book in the last three quarters has grown to 40%. - The order book is the highest seen over the last three quarters, reflecting growing traction. - There is a known pipeline of inquiries for larger projects, particularly with the new GenX facility coming online, signaling expected future order growth.
Key Metrics
Frequently Asked Questions
What were Praj Industries Ltd Q4 FY25 results?
- Targeting 3x revenue growth by 2030, aiming for Rs. - Praj Industries targets 3x revenue growth and 5x bottom-line growth by FY30 (Page 13).
What is Praj Industries Ltd share price analysis?
Praj Industries Ltd currently shows a neutral. The stock trades at a P/E of 293.6 with a market cap of ₹5,841. Investors should review the full earnings analysis for detailed insights.
Is Praj Industries Ltd planning capital expenditure?
- Formation of JV between Praj and BPCL approved by respective boards to set up CBG plants across India.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
